[Form 4] VERISIGN INC/CA Insider Trading Activity

Rhea-AI Filing Summary

Verisign insider transactions: D. James Bidzos, who is listed as Exec. Chairman, President and CEO, reported multiple sales of Verisign common stock on September 16-17, 2025. The filings show five sale entries totaling 7,000 shares sold in aggregate at weighted-average prices ranging from approximately $286.591 to $290.0325 per share, with individual trade-weighted price ranges disclosed in the explanations. After these reported disposals, the reporting person beneficially owned 478,438.7009 shares of Verisign common stock. The Form 4 was signed by a power of attorney on behalf of Mr. Bidzos.

Positive

• Reporting person remains Exec. Chairman, President & CEO and a Director
• Substantial continuing beneficial ownership: 478,438.7009 shares remain after the reported sales

Negative

• Reported open-market sales totaling 7,000 shares on 09/16/2025 and 09/17/2025
• Sales executed at weighted-average prices with price ranges up to $290.59 per share as disclosed in explanatory notes

Insights

Securities Analyst

TL;DR: Executive officer sold 7,000 shares over two days; remaining beneficial ownership remains large.

The transactions are disclosed as open-market sales across two days (September 16-17, 2025) with weighted-average prices reported for grouped trades. Total shares sold equal 7,000, leaving reported beneficial ownership at 478,438.7009 shares. These filings are routine Section 16 disclosures and do not include any indication of derivative transactions or amendments that would change economic exposure. The report was executed by a power of attorney, which is common for Form 4 filings.

Corporate Governance Expert

TL;DR: Board-level executive reported minor disposition; no governance changes disclosed.

The reporting person is identified as a Director and as Exec. Chairman, President & CEO, and the Form 4 documents only non-derivative sales. There is no information in the filing about changes in roles, pledges, loans, or related-party transactions. The signature by power of attorney is noted and the explanatory footnotes transparently disclose price ranges for the grouped sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BIDZOS D JAMES

(Last) (First) (Middle)

12061 BLUEMONT WAY

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERISIGN INC/CA [ VRSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Chairman, Pres, & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		S		1,000	D	$286.591(1)	484,438.7009	D
Common Stock	09/16/2025		S		4,000	D	$287.5316(2)	480,438.7009	D
Common Stock	09/17/2025		S		1,086	D	$287.7086(3)	479,352.7009	D
Common Stock	09/17/2025		S		514	D	$288.9073(4)	478,838.7009	D
Common Stock	09/17/2025		S		400	D	$290.0325(5)	478,438.7009	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $286.16 to $287.05, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $287.17 to $288.13, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $287.35 to $288.17, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $288.50 to $289.40, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

5. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $289.61 to $290.59, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

	Thomas C. Indelicarto by Power of Attorney for D. James Bidzos	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did D. James Bidzos report on Form 4 for VRSN?

The Form 4 reports non-derivative sales totaling 7,000 shares of Verisign common stock on September 16-17, 2025 and shows 478,438.7009 shares beneficially owned after the transactions.

What prices were the VRSN shares sold at in the Form 4?

The filing reports weighted-average prices for grouped sales: $286.591, $287.5316, $287.7086, $288.9073, and $290.0325, with disclosed underlying price ranges in the explanations.

Does the Form 4 show any option exercises or derivative transactions for VRSN?

No. Table II (derivative securities) contains no reported acquisitions or dispositions; the filing only reports non-derivative common stock sales.

Who signed the Form 4 for D. James Bidzos?

The Form 4 was signed by Thomas C. Indelicarto by Power of Attorney for D. James Bidzos on 09/17/2025.